rs1008224442
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001035.3(RYR2):c.13449A>G(p.Lys4483Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,612,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001035.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- arrhythmogenic right ventricular dysplasia 2Inheritance: AD Classification: DEFINITIVE, NO_KNOWN Submitted by: Laboratory for Molecular Medicine, Ambry Genetics
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
- catecholaminergic polymorphic ventricular tachycardia 1Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RYR2 | NM_001035.3 | c.13449A>G | p.Lys4483Lys | synonymous_variant | Exon 92 of 105 | ENST00000366574.7 | NP_001026.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RYR2 | ENST00000366574.7 | c.13449A>G | p.Lys4483Lys | synonymous_variant | Exon 92 of 105 | 1 | NM_001035.3 | ENSP00000355533.2 | ||
| RYR2 | ENST00000661330.2 | c.13467A>G | p.Lys4489Lys | synonymous_variant | Exon 93 of 106 | ENSP00000499393.2 | ||||
| RYR2 | ENST00000609119.2 | n.*4541A>G | non_coding_transcript_exon_variant | Exon 91 of 104 | 5 | ENSP00000499659.2 | ||||
| RYR2 | ENST00000609119.2 | n.*4541A>G | 3_prime_UTR_variant | Exon 91 of 104 | 5 | ENSP00000499659.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152246Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000811 AC: 2AN: 246624 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1459816Hom.: 0 Cov.: 30 AF XY: 0.00000689 AC XY: 5AN XY: 726014 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74376 show subpopulations
ClinVar
Submissions by phenotype
not specified Benign:1
This synonymous variant is a silent variation that is not predicted to change the amino acid sequence of the protein and has occurred in gnomAD with a total MAF of 0.0008% and with the highest MAF of 0.0018% in the European population. This variant has been reported in ClinVar (463566) NM_001035.3(RYR2):c.13449A>G (p.Lys4483=). This position is not conserved. In silico splicing algorithms predicted no impact on splicing (not found in scSNV and is 28 bases away from the canonical splice-site in transcript, NM_001035.2). The variant has not occurred in the literature in the association with the disease. Considering the splice distance and that it is a silent change that does not have an apparent effect on RNA splicing machinery, the variant has been classified as Likely Benign.
Catecholaminergic polymorphic ventricular tachycardia Benign:1
Cardiomyopathy Benign:1
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at